IS4871A - Setnar indasól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerð IV lata og framleiðsla á æxlis drepþætti (TNF) - Google Patents

Setnar indasól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerð IV lata og framleiðsla á æxlis drepþætti (TNF)

Info

Publication number: IS4871A
Authority: IS; Iceland
Prior art keywords: pde; phosphodiesterase; tnf; inhibitors; established
Prior art date: 1996-05-03

Application number

IS4871A

Other languages

English (en)

Inventor

Marfat Anthony

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-03

Filing date

1998-10-16

Publication date

1998-10-16

1998-10-16 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1998-10-16 Publication of IS4871A publication Critical patent/IS4871A/is

Links

102000004861 Phosphoric Diester Hydrolases Human genes 0.000 title 2
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 title 2
108060008682 Tumor Necrosis Factor Proteins 0.000 title 2
102000003390 tumor necrosis factor Human genes 0.000 title 2
125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Obesity (AREA)
Tropical Medicine & Parasitology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IS4871A 1996-05-03 1998-10-16 Setnar indasól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerð IV lata og framleiðsla á æxlis drepþætti (TNF) IS4871A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1686196P	1996-05-03	1996-05-03
PCT/IB1997/000323 WO1997042174A1 (en)	1996-05-03	1997-04-01	Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)

Publications (1)

Publication Number	Publication Date
IS4871A true IS4871A (is)	1998-10-16

Family

ID=21779401

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4871A IS4871A (is)	1996-05-03	1998-10-16	Setnar indasól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerð IV lata og framleiðsla á æxlis drepþætti (TNF)

Country Status (41)

Country	Link
US (2)	US6211222B1 (is)
EP (1)	EP0912521B1 (is)
JP (1)	JP3148254B2 (is)
KR (1)	KR100339935B1 (is)
CN (2)	CN1112359C (is)
AP (4)	AP1147A (is)
AR (1)	AR006906A1 (is)
AT (1)	ATE292626T1 (is)
AU (1)	AU725576B2 (is)
BG (1)	BG64211B1 (is)
BR (1)	BR9709051A (is)
CA (2)	CA2252982C (is)
CO (1)	CO4650038A1 (is)
CZ (1)	CZ292825B6 (is)
DE (1)	DE69732966T2 (is)
DZ (1)	DZ2217A1 (is)
EA (1)	EA002272B1 (is)
ES (1)	ES2238079T3 (is)
GT (1)	GT199700043A (is)
HN (1)	HN1997000046A (is)
HR (1)	HRP970227B1 (is)
HU (1)	HUP9902459A3 (is)
ID (1)	ID16856A (is)
IL (2)	IL126547A (is)
IS (1)	IS4871A (is)
MA (1)	MA24158A1 (is)
MY (1)	MY132499A (is)
NO (1)	NO312959B1 (is)
NZ (1)	NZ332240A (is)
OA (1)	OA10904A (is)
PE (1)	PE64598A1 (is)
PL (1)	PL329836A1 (is)
SK (1)	SK148298A3 (is)
TN (1)	TNSN97070A1 (is)
TR (1)	TR199802202T2 (is)
TW (1)	TW449585B (is)
UA (1)	UA65536C2 (is)
UY (1)	UY24532A1 (is)
WO (1)	WO1997042174A1 (is)
YU (1)	YU16397A (is)
ZA (1)	ZA973804B (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6005118A (en) *	1996-05-03	1999-12-21	Caron; Stephane	Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
AP1147A (en) *	1996-05-03	2003-02-25	Pfizer	Substituted indazole derivatives and related compounds.
WO1997048697A1 (en)	1996-06-19	1997-12-24	Rhone-Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
DK0983249T3 (da)	1997-05-08	2002-07-08	Pfizer Prod Inc	Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater
IL126745A (en) *	1997-11-04	2003-09-17	Pfizer Prod Inc	Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
US6391872B1 (en) *	1997-11-04	2002-05-21	Pfizer Inc	Indazole bioisostere replacement of catechol in therapeutically active compounds
US6716978B2 (en) *	1997-11-04	2004-04-06	Pfizer Inc	Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
IL132407A0 (en) *	1998-10-21	2001-03-19	Pfizer Prod Inc	Method for treating congestive heart failure
JP2000198734A (ja) *	1998-12-30	2000-07-18	Pfizer Inc	胃運動性減弱および関連疾患の治療のための運動性増強薬
US6303782B1 (en) *	1999-04-20	2001-10-16	Pfizer Inc	Process for preparing benzylnitriles
US6362213B1 (en)	1999-12-23	2002-03-26	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
PT1244649E (pt) *	1999-12-23	2005-06-30	Icos Corp	Inibidores de fosfodiesterase especificos de mfa ciclica
US6897231B2 (en) *	2000-07-31	2005-05-24	Signal Pharmaceuticals, Inc.	Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US7211594B2 (en) *	2000-07-31	2007-05-01	Signal Pharmaceuticals, Llc	Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
US6953774B2 (en)	2000-08-11	2005-10-11	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation
DK1908463T3 (da)	2001-12-14	2011-11-28	Merck Serono Sa	Fremgangsmåder til at inducere ægløsning ved anvendelse af en ikke polypeptid-CAMP-niveaumodulator
US20040034084A1 (en) *	2002-05-24	2004-02-19	Celgene Corporation	Methods for using JNK inhibitors for treating or preventing disease-related wasting
US7196082B2 (en) *	2002-11-08	2007-03-27	Merck & Co. Inc.	Ophthalmic compositions for treating ocular hypertension
US20050019366A1 (en) *	2002-12-31	2005-01-27	Zeldis Jerome B.	Drug-coated stents and methods of use therefor
DE10318610A1 (de)	2003-04-24	2004-11-11	Elbion Ag	7-Azaindole und deren Verwendung als Therapeutika
US7601847B2 (en)	2004-10-26	2009-10-13	Wyeth	Preparation and purification of 4-(indazol-3-yl)phenols
US20070004777A1 (en) *	2005-03-23	2007-01-04	Bhagwat Shripad S	Methods for treating or preventing acute myelogenous leukemia
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
WO2007124414A2 (en) *	2006-04-21	2007-11-01	Centocor, Inc.	Cxcl13 antagonists and their use for the treatment of inflammatory diseases
AU2007249399A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
IL274444B2 (en)	2017-11-06	2024-06-01	Rapt Therapeutics Inc	Chemokine receptor modulators for the treatment of Epstein-Barr virus-positive cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3994890A (en) *	1974-01-31	1976-11-30	Chugai Seiyaku Kabushiki Kaisha	1-Aminoalkyl, 3-phenyl indazoles
JPS5654437A (en) *	1979-10-09	1981-05-14	Konishiroku Photo Ind Co Ltd	Direct positive image forming method
GB8707051D0 (en) *	1986-04-15	1987-04-29	Ici America Inc	Heterocyclic carboxamides
JP2525286B2 (ja) *	1990-11-26	1996-08-14	日本原子力研究所	超耐熱性炭化ケイ素繊維の製造方法
TW223004B (is) *	1991-11-25	1994-05-01	Sumitomo Chemical Co
US5444038A (en) *	1992-03-09	1995-08-22	Zeneca Limited	Arylindazoles and their use as herbicides
DE69328964T2 (de) *	1992-03-09	2000-11-09	Zeneca Ltd., London	Arylindazoline und ihre anwendung als herbizide
CA2133439C (en) *	1992-04-02	2005-07-26	Siegfried Benjamin Christensen, Iv	Compounds useful for treating allergic and inflammatory diseases
US5554620A (en) *	1993-09-14	1996-09-10	Sterling Winthrop Inc.	Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
US5440038A (en) *	1993-12-07	1995-08-08	Miles Inc.	Process for the purification of substituted 4-amino-1,2,4-triazine-5-ones
PL319758A1 (en) *	1994-10-20	1997-08-18	Pfizer	Bicyclic tetrahydropyrasole pyridines and their application as medicines
DE69516298T2 (de) *	1994-10-21	2000-12-28	Elisha Technologies Co. L.L.C., Moberly	Korrosionsverhinderndes puffer-system für metallprodukte
AP1147A (en) *	1996-05-03	2003-02-25	Pfizer	Substituted indazole derivatives and related compounds.
DK0983249T3 (da) *	1997-05-08	2002-07-08	Pfizer Prod Inc	Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater

1996
- 1996-05-03 AP APAP/P/2001/002294A patent/AP1147A/en active
- 1996-05-03 AP AP2001002304A patent/AP2001002304A0/xx unknown
1997
- 1997-01-04 UA UA98105434A patent/UA65536C2/uk unknown
- 1997-04-01 NZ NZ332240A patent/NZ332240A/xx unknown
- 1997-04-01 SK SK1482-98A patent/SK148298A3/sk unknown
- 1997-04-01 TR TR1998/02202T patent/TR199802202T2/xx unknown
- 1997-04-01 PL PL97329836A patent/PL329836A1/xx unknown
- 1997-04-01 AT AT97907247T patent/ATE292626T1/de not_active IP Right Cessation
- 1997-04-01 EP EP97907247A patent/EP0912521B1/en not_active Expired - Lifetime
- 1997-04-01 KR KR1019980708867A patent/KR100339935B1/ko not_active Expired - Fee Related
- 1997-04-01 DE DE69732966T patent/DE69732966T2/de not_active Expired - Fee Related
- 1997-04-01 IL IL12654797A patent/IL126547A/xx not_active IP Right Cessation
- 1997-04-01 TW TW086104176A patent/TW449585B/zh active
- 1997-04-01 AP APAP/P/2001/002304A patent/AP0102304A0/en unknown
- 1997-04-01 IL IL15208397A patent/IL152083A0/xx unknown
- 1997-04-01 BR BR9709051A patent/BR9709051A/pt active Search and Examination
- 1997-04-01 CA CA002252982A patent/CA2252982C/en not_active Expired - Fee Related
- 1997-04-01 JP JP53967097A patent/JP3148254B2/ja not_active Expired - Fee Related
- 1997-04-01 AU AU19373/97A patent/AU725576B2/en not_active Ceased
- 1997-04-01 ES ES97907247T patent/ES2238079T3/es not_active Expired - Lifetime
- 1997-04-01 CN CN97194356A patent/CN1112359C/zh not_active Expired - Fee Related
- 1997-04-01 HU HU9902459A patent/HUP9902459A3/hu unknown
- 1997-04-01 EA EA199800882A patent/EA002272B1/ru not_active IP Right Cessation
- 1997-04-01 CZ CZ19983492A patent/CZ292825B6/cs not_active IP Right Cessation
- 1997-04-01 CA CA002389918A patent/CA2389918A1/en not_active Abandoned
- 1997-04-01 WO PCT/IB1997/000323 patent/WO1997042174A1/en not_active Ceased
- 1997-04-04 HN HN1997000046A patent/HN1997000046A/es unknown
- 1997-04-10 GT GT199700043A patent/GT199700043A/es unknown
- 1997-04-28 UY UY24532A patent/UY24532A1/es not_active IP Right Cessation
- 1997-04-29 AR ARP970101769A patent/AR006906A1/es not_active Application Discontinuation
- 1997-04-29 YU YU16397A patent/YU16397A/sh unknown
- 1997-04-30 DZ DZ970064A patent/DZ2217A1/fr active
- 1997-04-30 AP APAP/P/1997/000975A patent/AP1146A/en active
- 1997-04-30 TN TNTNSN97070A patent/TNSN97070A1/fr unknown
- 1997-04-30 PE PE1997000330A patent/PE64598A1/es not_active Application Discontinuation
- 1997-04-30 MA MA24577A patent/MA24158A1/fr unknown
- 1997-05-02 MY MYPI97001923A patent/MY132499A/en unknown
- 1997-05-02 ID IDP971466A patent/ID16856A/id unknown
- 1997-05-02 ZA ZA973804A patent/ZA973804B/xx unknown
- 1997-05-02 HR HR970227A patent/HRP970227B1/xx not_active IP Right Cessation
- 1997-05-05 CO CO97023872A patent/CO4650038A1/es unknown
- 1997-11-04 US US08/963,904 patent/US6211222B1/en not_active Expired - Fee Related
1998
- 1998-10-16 IS IS4871A patent/IS4871A/is unknown
- 1998-10-23 OA OA9800201A patent/OA10904A/en unknown
- 1998-11-02 NO NO19985095A patent/NO312959B1/no not_active IP Right Cessation
- 1998-11-23 BG BG102946A patent/BG64211B1/bg unknown
1999
- 1999-09-27 US US09/406,220 patent/US6127398A/en not_active Expired - Fee Related
2002
- 2002-11-08 CN CN02149950A patent/CN1422849A/zh active Pending

Also Published As

Publication number	Publication date
HUP9902459A2 (hu)	1999-11-29
HRP970227A2 (en)	2000-12-31
NZ332240A (en)	2000-07-28
HK1019443A1 (en)	2000-02-11
US6211222B1 (en)	2001-04-03
CZ292825B6 (cs)	2003-12-17
IL126547A0 (en)	1999-08-17
YU16397A (sh)	1999-12-27
HUP9902459A3 (en)	2001-10-29
NO985095L (no)	1998-12-29
TNSN97070A1 (fr)	2005-03-15
ZA973804B (en)	1998-11-02
US6127398A (en)	2000-10-03
UY24532A1 (es)	2000-09-29
CA2389918A1 (en)	1997-11-13
CA2252982A1 (en)	1997-11-13
AP0102304A0 (en)	1997-11-03
BR9709051A (pt)	1999-08-03
AP1147A (en)	2003-02-25
WO1997042174A1 (en)	1997-11-13
AP2001002304A0 (en)	2001-12-31
PE64598A1 (es)	1998-10-26
TW449585B (en)	2001-08-11
IL126547A (en)	2003-03-12
AP2001002294A0 (en)	2001-12-31
MA24158A1 (fr)	1997-12-31
EA199800882A1 (ru)	1999-06-24
CZ349298A3 (cs)	1999-09-15
DE69732966T2 (de)	2005-09-08
TR199802202T2 (xx)	1999-02-22
HRP970227B1 (en)	2002-06-30
MY132499A (en)	2007-10-31
CO4650038A1 (es)	1998-09-03
AU1937397A (en)	1997-11-26
AU725576B2 (en)	2000-10-12
HN1997000046A (es)	1997-06-26
DE69732966D1 (de)	2005-05-12
CA2252982C (en)	2002-10-08
CN1112359C (zh)	2003-06-25
SK148298A3 (en)	2000-02-14
CN1422849A (zh)	2003-06-11
PL329836A1 (en)	1999-04-12
JPH11508284A (ja)	1999-07-21
ES2238079T3 (es)	2005-08-16
BG102946A (en)	1999-11-30
AP9700975A0 (en)	1997-07-31
EP0912521A1 (en)	1999-05-06
KR20000010751A (ko)	2000-02-25
EP0912521B1 (en)	2005-04-06
KR100339935B1 (ko)	2002-07-18
NO985095D0 (no)	1998-11-02
BG64211B1 (bg)	2004-05-31
ATE292626T1 (de)	2005-04-15
UA65536C2 (en)	2004-04-15
ID16856A (id)	1997-11-13
DZ2217A1 (fr)	2002-12-03
JP3148254B2 (ja)	2001-03-19
CN1217714A (zh)	1999-05-26
IL152083A0 (en)	2003-05-29
AR006906A1 (es)	1999-09-29
NO312959B1 (no)	2002-07-22
GT199700043A (es)	1998-10-02
OA10904A (en)	2001-10-11
EA002272B1 (ru)	2002-02-28
AP1146A (en)	2003-02-25

Publication	Publication Date	Title
IS4871A (is)	1998-10-16	Setnar indasól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerð IV lata og framleiðsla á æxlis drepþætti (TNF)
IS4979A (is)	1999-02-16	Indazól afleiður og notkun þeirra sem lata fyrir gerð IV af fosfódíesterasa (PDE) og fyrir framleiðslu á æxlisdreps þætti (TNF)
IS4910A (is)	1998-11-27	Setnar indazól afleiður og notkun þeirra sem fosfódíesterasa (PDE) gerðar IV og æxlisdrepsþáttar lata
FI950859A7 (fi)	1995-02-24	Arylideeni- ja heteroarylideeni-oksindolijohdannaiset tyrosiinikinaasi-inhibiittoreina
AU2396897A (en)	1997-11-12	5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
FI981437L (fi)	1998-08-25	PDE III, PDE IV ja TNF inhibiittoreina käyttökelpoisia imidejä
SI1475377T1 (sl)	2006-12-31	Indolni derivati in njihova uporaba kot inhibitorji fosfodiesteraze 4
AU5704594A (en)	1994-07-19	Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
HUP0102113A1 (hu)	2001-12-28	2-(2,6-Dioxo-piperidin-3-il)-izoindolinszármazékok, előállításuk és alkalmazásuk, mint a gyulladáskeltő citokinek inhibitorai
NO20000487L (no)	2000-03-31	Substituerte quinazolinderivater og anvendelse derav som tyrosin-kinase-inhibitorer
GB9613021D0 (en)	1996-08-28	Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU4501199A (en)	1999-12-20	8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
MXPA02009550A (es)	2004-05-14	Derivados de pirano (2,3,c)imidazo(1,2-a]piridina para el tratamiento de trastornos gastrointestinales.
AU2876000A (en)	2000-08-29	Tyrosine kinase inhibitors and methods of using the same
GB0102712D0 (en)	2001-03-21	Cytokine Producion and Tyrosine Kinase Inhibitors
GB0511267D0 (en)	2005-07-13	Indol derivatives and their use as kinase inhibitors
HK1057013A (en)	2004-03-12	Indazole derivatives as jnk inhibitors
HK1079192A (en)	2006-03-31	Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors